<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="brief-report" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<?covid-19-tdm?>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Big Data</journal-id>
<journal-title>Frontiers in Big Data</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Big Data</abbrev-journal-title>
<issn pub-type="epub">2624-909X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">631073</article-id>
<article-id pub-id-type="doi">10.3389/fdata.2021.631073</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Big Data</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>COVID-19 as a Research Dynamic Transformer: Emerging Cross-Disciplinary and National Characteristics</article-title>
<alt-title alt-title-type="left-running-head">Ohniwa et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">COVID-19 and Researcher Dynamics</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ohniwa</surname>
<given-names>Ryosuke L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="FN1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1145586/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kijima</surname>
<given-names>Joji</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="FN1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fukushige</surname>
<given-names>Mizuho</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1312007/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohneda</surname>
<given-names>Osamu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/576237/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Faculty of Medicine, University of Tsukuba, <addr-line>Tsukuba</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Center for Biotechnology, National Taiwan University, <addr-line>Taipei</addr-line>, <country>Taiwan</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Bureau of Global Initiatives, University of Tsukuba, <addr-line>Tsukuba</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/477612/overview">Reza Lashgari</ext-link>, ShahidBeheshti University,&#x20;Iran</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/532820/overview">Gregory R. Hart</ext-link>, Yale University, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1339119/overview">SohrabNajafian</ext-link>, SUNY College of Optometry, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1348245/overview">Mahdi Mahdavi</ext-link>, ShahidBeheshti University of Medical Sciences,&#x20;Iran</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Ryosuke L. Ohniwa, <email>ohniwa@md.tsukuba.ac.jp</email>
</corresp>
<fn fn-type="equal" id="FN1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Medicine and Public Health, a section of the journal Frontiers in Big&#x20;Data</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>07</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>4</volume>
<elocation-id>631073</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>06</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Ohniwa, Kijima, Fukushige and Ohneda.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Ohniwa, Kijima, Fukushige and Ohneda</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>The outbreak of the COVID-19 pandemic has had an unprecedented impact on humanity as well as research activities in life sciences and medicine. Between January and August 2020, the number of coronavirus-related scientific articles was roughly 50&#x20;times more than that of articles published in the entire year of 2019 in PubMed. It is necessary to better understand the dynamics of research on COVID-19, an emerging topic, and suggest ways to understand and improve the quality of research. We analyze the dynamics of coronavirus research before and after the outbreaks of SARS, MERS, and COVID-19 by examining all the published articles from the past 25&#xa0;years in PubMed. We delineate research networks on coronaviruses as we identify experts&#x2019; background in terms of topics of previous research, affiliations, and international co-authorships. Two distinct dynamics of coronavirus research were found: 1) in the cases of regional pandemics, SARS and MERS, the scope of cross-disciplinary research remained between neighboring research areas; 2) in the case of the global pandemic, COVID-19, research activities have spread beyond neighboring disciplines with little transnational collaboration. Thus, COVID-19 has transformed the structure of research on coronaviruses as an emerging issue. Knowledge on COVID-19 is distributed across the widest range of disciplines, transforming research networks well beyond the field of medicine but within national boundaries. Given the unprecedented scale of COVID-19 and the nationalization of responses, the most likely way forward is to accumulate local knowledge with the awareness of transdisciplinary research dynamics.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>coronavirus research</kwd>
<kwd>researcher dynamics</kwd>
<kwd>PubMed</kwd>
<kwd>scientometrics</kwd>
</kwd-group>
<contract-num rid="cn001">20K00266</contract-num>
<contract-sponsor id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">University of Tsukuba<named-content content-type="fundref-id">10.13039/501100006559</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>COVID-19 [SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)]&#x2014;since first reported in Wuhan, China, in December 2019&#x2014;has spread around the globe with more than 172&#xa0;million confirmed cases and more than three million deaths from December 2019 to June 2021(WHO 2021). Earlier in this century, the world was also plagued by the outbreaks of SARS [SARS-CoV (severe acute respiratory syndrome coronavirus)]&#x2014;originating from Guangdong Province, China, in November 2002 (<xref ref-type="bibr" rid="B13">Rosling and Rosling, 2003</xref>;<xref ref-type="bibr" rid="B22">Xu et&#x20;al., 2004</xref>)&#x2014;and MERS [MERS-CoV (Middle East respiratory syndrome coronavirus)] that emerged in March 2012 (<xref ref-type="bibr" rid="B9">Hijawi et&#x20;al., 2013</xref>;<xref ref-type="bibr" rid="B3">Cauchemez et&#x20;al., 2014</xref>). In the 21st century, coronaviruses have become the root causes of emerging infectious diseases in the world (<xref ref-type="bibr" rid="B7">Guarner, 2020</xref>;<xref ref-type="bibr" rid="B20">Wang et&#x20;al., 2020</xref>).</p>
<p>Meanwhile, the number of scientific research articles on coronaviruses in the fields of life sciences and medicine has increased dramatically (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). In the case of SARS-CoV, the number of publications increased fivefold by 2003&#x2014;in just one year after the outbreak. In the case of MERS-CoV, the number increased steadily from the year after the outbreak in 2012 and doubled by 2015. In the case of SARS-CoV2, the number of research articles published between January 2020 and August 2020 was 50&#x20;times more than the number of scientific publications on coronaviruses in the entire year of 2019 (see Results). Indeed, coronaviruses have become an emerging research topic as a result (<xref ref-type="bibr" rid="B14">Rotolo et&#x20;al., 2015</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Number of articles on coronaviruses published in PubMed. The number of articles was counted on Aug 17th, 2020. &#x201c;All articles&#x201d; represents the total number of articles found in PubMed as published in each year (the scale is shown in the left <italic>x</italic> axis). &#x201c;Coronavirus-related articles&#x201d; represents the total number of articles found by the query of &#x201c;coronavirus OR COVID-19 OR SARS-CoV OR MERS-CoV&#x201d; (the scale is shown in the right <italic>x</italic> axis).</p>
</caption>
<graphic xlink:href="fdata-04-631073-g001.tif"/>
</fig>
<p>It has been shown by bibliometric and sociological studies that researchers tend to publish articles on topics outside of their own area of expertise and begin diversifying their publications once certain topics&#x2014;such as new technologies and concepts&#x2014;are recognized as something scientifically valuable in the forthcoming future. That is how the corresponding topics become &#x201c;emerging&#x201d; (<xref ref-type="bibr" rid="B18">Van Merkerk and Van Lente, 2005</xref>;<xref ref-type="bibr" rid="B2">Borup et&#x20;al., 2006</xref>;<xref ref-type="bibr" rid="B8">Gustafsson et&#x20;al., 2015</xref>). At the same time, the rapid growth of publications makes these emerging topics the foci of cross-disciplinary studies (<xref ref-type="bibr" rid="B14">Rotolo et&#x20;al., 2015</xref>). However, more studies are needed to adequately understand the relationship between emerging topics&#x2014;such as infectious diseases&#x2014;and the scope of cross-disciplinary research. This study aimed to fill part of that gap in the literature on the relationship between the emerging topics.</p>
<p>In this study, we analyze the Medical Subject Headings (MeSH) attached to PubMed (Medline) articles to identify the research topics and specialties of each researcher. PubMed (Medline), a literature database search engine run by the National Library of Medicine (NLM), contains approximately 10&#xa0;million articles. MeSH is a popular keyword thesaurus developed by NLM, and it is typically used in PubMed to support literature searches (<xref ref-type="bibr" rid="B15">Lipscomb, 2000</xref>). It is attached to each article under the supervision of professional curators according to article contents (<xref ref-type="bibr" rid="B10">Lowe and Barnett, 1994</xref>). We have developed a method to identify emerging topics as clusters of emerging MeSH terms (<xref ref-type="bibr" rid="B12">Ohniwa et&#x20;al., 2010</xref>;<xref ref-type="bibr" rid="B11">Ohniwa and Hibino, 2019</xref>). For the present study, we have modified this method to identify the characteristics of research topics and areas of expertise by selecting unique MeSH terms instead of those emerging (see Materials and Methods).</p>
<p>We investigate all the articles in PubMed between 1996 and 2020 to elucidate the following: 1) trends in coronavirus research before and after the outbreaks of the novel coronavirus infectious diseases&#x2014;namely, SARS, MERS, and COVID-19&#x2014;in terms of their impact on the nature of research; 2) the dynamics of how researchers venture across disciplinary boundaries to tackle emerging topics in times of crises by identifying their areas of research prior to the outbreaks and their countries of origin; and 3) the relational mechanism between cross-disciplinary research and transnational collaboration on coronaviruses. The results indicate the current COVID-19 pandemic has transformed coronavirus research into a nationalized body of knowledge across a wider range of disciplines. Finally, we suggest the most likely way forward for coronavirus research and draw an implication from the transformation of research dynamics based on the concepts of &#x201c;transdisciplinarity (<xref ref-type="bibr" rid="B17">Stenner, 2017</xref>)&#x201d; and &#x201c;event (<xref ref-type="bibr" rid="B21">Whitehead, 1925</xref>)&#x201d;.</p>
</sec>
<sec id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Dataset</title>
<p>MeSH terms attached to articles published between 1996 and 2020 were collected through PubMed (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/">https://www.ncbi.nlm.nih.gov/pubmed/</ext-link>) on August 17th, 2020. A total of 21,706,508 articles were included in the analysis.</p>
<p>MeSH terms attached on each article were identified from the XML data, and any overlaps in terms for each article were eliminated by our original Perl scripts as described in our previous articles (<xref ref-type="bibr" rid="B12">Ohniwa et&#x20;al., 2010</xref>;<xref ref-type="bibr" rid="B11">Ohniwa and Hibino, 2019</xref>). Here, to identify the set of MeSH terms attached to each article, terms tagged as &#x3c;DescriptorNameUI &#x3d; @&#x3e; and &#x3c;NameOfSubstance UI &#x3d; @&#x3e; from the XML data (@ represents each UI) were extracted, and then overlaps in the terms for each article were eliminated by Perl with our original scripts. Then, to eliminate the terms not concerned with research topics, all the MeSH terms under the following hierarchies were excluded: &#x201c;Geographicals [Z],&#x201d;&#x201c;Publication Characteristics [V],&#x201d;&#x201c;Named Groups [M],&#x201d;&#x201c;Health Care [N],&#x201d;&#x201c;Information Services [L01.453],&#x201d;&#x201c;Communications Media [L01.178],&#x201d;&#x201c;Communication [L01.143],&#x201d;&#x201c;Information Centers [L01.346],&#x201d; and &#x201c;Publishing [L01.737]&#x201d; according to the 2018 MeSH Tree Hierarchy (<ext-link ext-link-type="uri" xlink:href="https://meshb-prev.nlm.nih.gov/search">https://meshb-prev.nlm.nih.gov/search</ext-link>). These categories involve MeSH terms which represent the style or the background of articles rather than its research contents. A total of 1,776,759 kinds of terms with a total of 957,790,657 occurrences were obtained between 1996 and 2020 by this operation.</p>
<p>To identify the sets of authors and affiliations attached to each article, terms tagged as &#x3c;AffiliationInfo&#x3e;, &#x3c;LastName&#x3e;, and &#x3c;Initials&#x3e; within &#x3c;Author ValidYN &#x3d; @&#x3e; (@ represents each &#x201c;Y or N&#x201d;) were extracted by our original Perl script. A total of 42,923,027 kinds of authors (with affiliation) with a total of 56,467,393 occurrences were obtained by this operation (in the case of only author name, a total of 7,395,577 kinds of authors with a total of 108,977,113 occurrences).</p>
<p>Coronavirus-related articles published between 1996 and 2020 were separately obtained by searching PubMed using the query terms of &#x201c;coronavirus OR COVID-19 OR SARS-CoV OR MERS-CoV.&#x201d; A total of 56,077 articles and 66,850 kinds of MeSH terms with a total of 1,739,841 occurrences were obtained between 1996 and 2020 by this operation. From these articles, a total of 252,292 kinds of authors (with affiliations) with a total of 273,759 occurrences were obtained (in the case of using only authors&#x2019; names, a total of 157,593 kinds of authors with a total of 337,946 occurrences).</p>
</sec>
<sec id="s2-2">
<title>Countries of Origin</title>
<p>The number of articles having the following words in the affiliation was counted: &#x201c;Argentina&#x201d;, &#x201c;Australia&#x201d;, &#x201c;Austria&#x201d;, &#x201c;Belgium&#x201d;, &#x201c;Brazil&#x201d;, &#x201c;Bulgaria&#x201d;, &#x201c;Canada&#x201d;, &#x201c;Chile&#x201d;, &#x201c;China (&#x2018;China&#x2019; or &#x2018;People&#x2019;s Republic of China&#x2019;)&#x201d;, &#x201c;Croatia&#x201d;, &#x201c;Czech Republic&#x201d;, &#x201c;Denmark&#x201d;, &#x201c;Egypt&#x201d;, &#x201c;Finland&#x201d;, &#x201c;France&#x201d;, &#x201c;Germany&#x201d;, &#x201c;Greece&#x201d;, &#x201c;HongKong&#x201d;, &#x201c;Hungary&#x201d;, &#x201c;India&#x201d;, &#x201c;Iran&#x201d;, &#x201c;Ireland&#x201d;, &#x201c;Israel&#x201d;, &#x201c;Italy&#x201d;, &#x201c;Japan&#x201d;, &#x201c;Korea&#x201d;, &#x201c;Malaysia&#x201d;, &#x201c;Mexico&#x201d;, &#x201c;Netherlands&#x201d;, &#x201c;New&#x20;Zealand&#x201d;, &#x201c;Norway&#x201d;, &#x201c;Pakistan&#x201d;, &#x201c;Poland&#x201d;, &#x201c;Portugal&#x201d;, &#x201c;Romania&#x201d;, &#x201c;Russia&#x201d;, &#x201c;Saudi Arabia&#x201d;, &#x201c;Singapore&#x201d;, &#x201c;Slovakia&#x201d;, &#x201c;Slovenia&#x201d;, &#x201c;South Africa&#x201d;, &#x201c;Spain&#x201d;, &#x201c;Sweden&#x201d;, &#x201c;Switzerland&#x201d;, &#x201c;Taiwan (&#x2018;Taiwan&#x2019; or &#x2018;Republic of China&#x2019;)&#x201d;, &#x201c;Thailand&#x201d;, &#x201c;Turkey&#x201d;, &#x201c;Ukraine&#x201d;, &#x201c;United Arab Emirates (&#x2018;UAE&#x2019; or &#x2018;United Arab Emirates&#x2019;)&#x201d;, &#x201c;United&#x20;Kingdom (&#x2018;England&#x2019;, &#x2018;U.K&#x2019;, &#x2018;UK&#x2019;, &#x2018;United&#x20;Kingdom&#x2019;, &#x2018;Scotland&#x2019;)&#x201d;, and &#x201c;United&#x20;States (&#x2018;USA&#x2019; or &#x2018;United&#x20;States&#x2019;)&#x201d;.</p>
</sec>
<sec id="s2-3">
<title>Unique Keywords</title>
<p>Among MeSH terms, we arbitrary defined unique keywords to coronavirus research as follows:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">&#x3b1;</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">in</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">&#x3b2;</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">B</mml:mi>
<mml:mi mathvariant="normal">&#x3b2;</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">&#x3b1;</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">in</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">&#x3b2;</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">&#x3b2;</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2265;</mml:mo>
<mml:mi mathvariant="normal">2</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>where A<sub>&#x3b1; in &#x3b2;</sub> is the number of appearances of the MeSH term &#x3b1; in years &#x3b2; found in coronavirus-related articles, B<sub>&#x3b2;</sub> is the total number of the coronavirus-related articles in years &#x3b2;, C<sub>&#x3b1; in &#x3b2;</sub> is the number of appearances of the MeSH term &#x3b1; in years &#x3b2; in PubMed, and D<sub>&#x3b2;</sub> is the total number of articles counted in years &#x3b2; in PubMed. The terms whose rates were more than 2 were defined as unique keywords. A total of 13,125 kinds of MeSH terms as unique keywords with a total of 1,739,841 occurrences were collected between 1996 and&#x20;2020.</p>
</sec>
<sec id="s2-4">
<title>Co-Word Analysis With Unique Keywords</title>
<p>Top 50 most frequently occurring unique keywords were collected for each period, and they were examined whether they coappeared in the same article. The coappearance was examined by using Perl with our original scripts. The coappearance of the keywords was visualized using Pajek software (<xref ref-type="bibr" rid="B1">Batagelj and Mrvar, 2002</xref>). To eliminate any weak relation among keywords, the threshold for making edges was set at 10% of the number of keywords (selecting smaller sized nodes) linked by the edges, according to the clusters appeared in the networks visualized by Pajek.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>The number of articles covering coronaviruses in the fields of life sciences and medicine rapidly increased in 2003 and decreased until 2011, and it increased again in 2015 and decreased until 2018 (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). From Jan 1st, 2020 to Aug 17th, 2020, the number reached 42,647, which is approximately 50&#x20;times more than the number, 831 articles, in 2019. This tendency coincided with the emergence of coronavirus infectious diseases such as the emergence of SARS in November 2002 (<xref ref-type="bibr" rid="B22">Xu et&#x20;al., 2004</xref>), MERS in November 2012 (<xref ref-type="bibr" rid="B9">Hijawi et&#x20;al., 2013</xref>;<xref ref-type="bibr" rid="B3">Cauchemez et&#x20;al., 2014</xref>), and COVID-19 in 2019. Once the diseases emerged, research on coronaviruses was rapidly activated and sustained for a few years. In the case of COVID-19, compared with SARS and MERS, the increment rate of the related articles was huge. Coronavirus has become an emerging research topic as a result (<xref ref-type="bibr" rid="B14">Rotolo et&#x20;al., 2015</xref>).</p>
<sec id="s3-1">
<title>By Topic: Cross-Disciplinary Consequences and the Scope of Impact</title>
<p>Regarding their impact on research contents, this study identified unique keywords which represented the characteristics of coronavirus research before and after the outbreaks of SARS, MERS, and COVID-19. Since the collection of frequently appeared MeSH terms by itself did not reveal the unique characteristics of the research contents owing to their generality of use in numerous articles (<xref ref-type="bibr" rid="B12">Ohniwa et&#x20;al., 2010</xref>), unique keywords from coronavirus research in a particular year were selected. These unique keywords defined as MeSH terms in coronavirus-related articles had the appearance rate that was at least twice as high as their appearance rate in all articles of the year (see Materials and Methods). This operation helped identify representative terms such as &#x201c;SARS Virus&#x201d; between 2003 and 2006 and &#x201c;Middle East Respiratory Syndrome Coronavirus&#x201d; between 2013 and 2016 as top 25 frequently appeared unique keywords (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). Keywords related to &#x201c;biological classification of coronaviruses,&#x201d;&#x201c;infection matters of coronaviruses,&#x201d; and &#x201c;respiratory tract issues [respiratory tract is the target infection site for coronaviruses as well as the site where its major symptom appears (<xref ref-type="bibr" rid="B5">Channappanavar and Perlman, 2017</xref>;<xref ref-type="bibr" rid="B16">Singhal, 2020</xref>)]&#x201d; were commonly used between 1996 and 2020&#x2014;consistent with the collection of unique keywords from coronavirus-related articles in this study. Keywords related to &#x201c;components of the virus&#x201d; and &#x201c;biological aspect&#x201d; were found in all of the years except for 2020, while others such as &#x201c;public health&#x201d; and &#x201c;human&#x201d; began to appear in 2020. When the list was expanded to top 50 frequently appeared unique keywords, this tendency was even strengthened (<xref ref-type="sec" rid="s9">Supplementary Table S1</xref>). In the meantime, conventional keywords such as &#x201c;immunology&#x201d; were still found in all of the years. In addition to the fact that these top 50 keywords frequently coappeared in the coronavirus-related articles (<xref ref-type="sec" rid="s9">Supplementary Figures S1&#x2013;S6</xref>), the results of this investigation suggest the following: 1) the regional outbreaks of SARS and MERS did not change the cross-disciplinary research trends that had existed before the outbreaks as keywords fell well within the scope of existing well-connected networks for coronavirus research focusing on the topics which had been constantly studied regardless of the outbreaks; 2) the global outbreak of COVD-19, on the other hand, initially had a diversifying impact on the existing research trend as newly emerged keywords formed unconnected research networks across different disciplines, including areas of research such as jurisprudence and public policy.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Top 25 unique keywords in coronavirus research articles.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">1996&#x2013;2002</th>
<th align="center">2003&#x2013;2006</th>
<th align="center">2007&#x2013;2012</th>
<th align="center">2013&#x2013;2016</th>
<th align="center">2017&#x2013;2019</th>
<th align="center">2020 Jan&#x2013;Aug</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Number of articles</td>
<td align="center">1,189</td>
<td align="center">3,180</td>
<td align="center">3,083</td>
<td align="center">3,427</td>
<td align="center">2,551</td>
<td align="center">42,647</td>
</tr>
<tr>
<td align="left">Viruses</td>
<td align="center">
<italic>1,113</italic>
</td>
<td align="center">
<italic>2,646</italic>
</td>
<td align="center">
<italic>2,631</italic>
</td>
<td align="center">
<italic>2,705</italic>
</td>
<td align="center">
<italic>1908</italic>
</td>
<td align="center">15,166</td>
</tr>
<tr>
<td align="left">RNA viruses</td>
<td align="center">
<italic>1,100</italic>
</td>
<td align="center">
<italic>2,611</italic>
</td>
<td align="center">
<italic>2,547</italic>
</td>
<td align="center">
<italic>2,596</italic>
</td>
<td align="center">
<italic>1828</italic>
</td>
<td align="center">15,154</td>
</tr>
<tr>
<td align="left">Nidovirales</td>
<td align="center">
<italic>1,058</italic>
</td>
<td align="center">
<italic>2,533</italic>
</td>
<td align="center">
<italic>2,349</italic>
</td>
<td align="center">
<italic>2,422</italic>
</td>
<td align="center">
<italic>1705</italic>
</td>
<td align="center">15,129</td>
</tr>
<tr>
<td align="left">Coronaviridae</td>
<td align="center">
<italic>1,051</italic>
</td>
<td align="center">
<italic>2,529</italic>
</td>
<td align="center">
<italic>2,337</italic>
</td>
<td align="center">
<italic>2,408</italic>
</td>
<td align="center">
<italic>1,697</italic>
</td>
<td align="center">15,129</td>
</tr>
<tr>
<td align="left">Coronavirus</td>
<td align="center">
<italic>1,046</italic>
</td>
<td align="center">
<italic>2,508</italic>
</td>
<td align="center">
<italic>2,311</italic>
</td>
<td align="center">
<italic>2,336</italic>
</td>
<td align="center">
<italic>1,682</italic>
</td>
<td align="center">15,126</td>
</tr>
<tr>
<td align="left">Proteins</td>
<td align="center">
<italic>706</italic>
</td>
<td align="left"/>
<td align="center">
<italic>1742</italic>
</td>
<td align="left"/>
<td align="center">
<italic>910</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Infections</td>
<td align="center">
<italic>655</italic>
</td>
<td align="center">
<italic>2092</italic>
</td>
<td align="center">
<italic>1894</italic>
</td>
<td align="center">
<italic>2,383</italic>
</td>
<td align="center">
<italic>1707</italic>
</td>
<td align="center">
<italic>17,959</italic>
</td>
</tr>
<tr>
<td align="left">Virus diseases</td>
<td align="center">
<italic>638</italic>
</td>
<td align="center">
<italic>2041</italic>
</td>
<td align="center">
<italic>1777</italic>
</td>
<td align="center">
<italic>2,259</italic>
</td>
<td align="center">
<italic>1,630</italic>
</td>
<td align="center">
<italic>17,939</italic>
</td>
</tr>
<tr>
<td align="left">RNA virus infections</td>
<td align="center">
<italic>602</italic>
</td>
<td align="center">
<italic>1960</italic>
</td>
<td align="center">
<italic>1,608</italic>
</td>
<td align="center">
<italic>2,103</italic>
</td>
<td align="center">
<italic>1,506</italic>
</td>
<td align="center">
<italic>17,929</italic>
</td>
</tr>
<tr>
<td align="left">Nidovirales infections</td>
<td align="center">
<italic>567</italic>
</td>
<td align="center">
<italic>1901</italic>
</td>
<td align="center">
<italic>1,473</italic>
</td>
<td align="center">
<italic>1972</italic>
</td>
<td align="center">
<italic>1,412</italic>
</td>
<td align="center">
<italic>17,914</italic>
</td>
</tr>
<tr>
<td align="left">Coronaviridae infections</td>
<td align="center">
<italic>565</italic>
</td>
<td align="center">
<italic>1899</italic>
</td>
<td align="center">
<italic>1,463</italic>
</td>
<td align="center">
<italic>1963</italic>
</td>
<td align="center">
<italic>1,410</italic>
</td>
<td align="center">
<italic>17,914</italic>
</td>
</tr>
<tr>
<td align="left">Coronavirus infections</td>
<td align="center">
<italic>551</italic>
</td>
<td align="center">
<italic>1884</italic>
</td>
<td align="center">
<italic>1,436</italic>
</td>
<td align="center">
<italic>1912</italic>
</td>
<td align="center">
<italic>1,406</italic>
</td>
<td align="center">
<italic>17,912</italic>
</td>
</tr>
<tr>
<td align="left">Cells</td>
<td align="center">
<italic>534</italic>
</td>
<td align="left"/>
<td align="center">
<italic>1,039</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Genetic phenomena</td>
<td align="center">
<italic>518</italic>
</td>
<td align="left"/>
<td align="center">
<italic>1,214</italic>
</td>
<td align="left"/>
<td align="center">
<italic>708</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Betacoronavirus</td>
<td align="center">
<italic>506</italic>
</td>
<td align="center">
<italic>1963</italic>
</td>
<td align="center">
<italic>1,270</italic>
</td>
<td align="center">
<italic>1,028</italic>
</td>
<td align="center">
<italic>715</italic>
</td>
<td align="center">14,995</td>
</tr>
<tr>
<td align="left">Rodentia</td>
<td align="center">
<italic>491</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Muridae</td>
<td align="center">
<italic>490</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Murinae</td>
<td align="center">
<italic>471</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Mice</td>
<td align="center">
<italic>459</italic>
</td>
<td align="left"/>
<td align="center">550</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Animal diseases</td>
<td align="center">
<italic>446</italic>
</td>
<td align="center">432</td>
<td align="center">
<italic>838</italic>
</td>
<td align="center">
<italic>1,006</italic>
</td>
<td align="center">
<italic>898</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Hepatitis viruses</td>
<td align="center">
<italic>414</italic>
</td>
<td align="center">212</td>
<td align="center">301</td>
<td align="center">132</td>
<td align="center">59</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Biochemical phenomena</td>
<td align="center">
<italic>412</italic>
</td>
<td align="left"/>
<td align="center">
<italic>1,035</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Murine hepatitis virus</td>
<td align="center">
<italic>408</italic>
</td>
<td align="center">191</td>
<td align="center">265</td>
<td align="center">103</td>
<td align="center">45</td>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Cells, cultured</td>
<td align="center">
<italic>379</italic>
</td>
<td align="center">
<italic>625</italic>
</td>
<td align="center">
<italic>784</italic>
</td>
<td align="center">
<italic>478</italic>
</td>
<td align="center">423</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Nucleic acids, nucleotides, and nucleosides</td>
<td align="center">
<italic>369</italic>
</td>
<td align="center">
<italic>704</italic>
</td>
<td align="center">698</td>
<td align="center">
<italic>494</italic>
</td>
<td align="center">342</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Genetic techniques</td>
<td align="center">352</td>
<td align="center">
<italic>860</italic>
</td>
<td align="center">
<italic>939</italic>
</td>
<td align="center">
<italic>782</italic>
</td>
<td align="center">
<italic>513</italic>
</td>
<td align="center">805</td>
</tr>
<tr>
<td align="left">Viral proteins</td>
<td align="center">343</td>
<td align="center">
<italic>913</italic>
</td>
<td align="center">
<italic>1,064</italic>
</td>
<td align="center">
<italic>705</italic>
</td>
<td align="center">
<italic>502</italic>
</td>
<td align="center">507</td>
</tr>
<tr>
<td align="left">Genetic structures</td>
<td align="center">333</td>
<td align="center">
<italic>624</italic>
</td>
<td align="center">599</td>
<td align="center">442</td>
<td align="center">290</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Nucleic acids</td>
<td align="center">327</td>
<td align="center">
<italic>590</italic>
</td>
<td align="center">595</td>
<td align="center">409</td>
<td align="center">298</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Molecular structure</td>
<td align="center">322</td>
<td align="center">
<italic>732</italic>
</td>
<td align="center">
<italic>737</italic>
</td>
<td align="center">456</td>
<td align="center">258</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Blood proteins</td>
<td align="center">290</td>
<td align="center">
<italic>570</italic>
</td>
<td align="center">497</td>
<td align="center">385</td>
<td align="center">309</td>
<td align="center">919</td>
</tr>
<tr>
<td align="left">Artiodactyla</td>
<td align="center">280</td>
<td align="left"/>
<td align="center">286</td>
<td align="center">
<italic>601</italic>
</td>
<td align="center">
<italic>603</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Microbiological phenomena</td>
<td align="center">264</td>
<td align="center">412</td>
<td align="center">680</td>
<td align="center">
<italic>684</italic>
</td>
<td align="center">
<italic>534</italic>
</td>
<td align="center">734</td>
</tr>
<tr>
<td align="left">Viral structural proteins</td>
<td align="center">258</td>
<td align="center">
<italic>653</italic>
</td>
<td align="center">673</td>
<td align="center">438</td>
<td align="center">343</td>
<td align="center">359</td>
</tr>
<tr>
<td align="left">Alphacoronavirus</td>
<td align="center">230</td>
<td align="center">196</td>
<td align="center">432</td>
<td align="center">
<italic>525</italic>
</td>
<td align="center">
<italic>539</italic>
</td>
<td align="center">49</td>
</tr>
<tr>
<td align="left">Virus physiological phenomena</td>
<td align="center">189</td>
<td align="center">345</td>
<td align="center">534</td>
<td align="center">
<italic>488</italic>
</td>
<td align="center">354</td>
<td align="center">481</td>
</tr>
<tr>
<td align="left">Swine</td>
<td align="center">160</td>
<td align="center">67</td>
<td align="center">174</td>
<td align="center">375</td>
<td align="center">
<italic>459</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Respiratory tract infections</td>
<td align="center">81</td>
<td align="center">
<italic>1,591</italic>
</td>
<td align="center">
<italic>866</italic>
</td>
<td align="center">
<italic>659</italic>
</td>
<td align="center">322</td>
<td align="center">
<italic>17,774</italic>
</td>
</tr>
<tr>
<td align="left">Disease outbreaks</td>
<td align="center">39</td>
<td align="center">404</td>
<td align="center">199</td>
<td align="center">389</td>
<td align="center">277</td>
<td align="center">
<italic>17,576</italic>
</td>
</tr>
<tr>
<td align="left">Pneumonia</td>
<td align="center">8</td>
<td align="center">53</td>
<td align="center">47</td>
<td align="center">74</td>
<td align="center">33</td>
<td align="center">
<italic>17,732</italic>
</td>
</tr>
<tr>
<td align="left">Pneumonia, viral</td>
<td align="center">4</td>
<td align="center">21</td>
<td align="center">24</td>
<td align="center">52</td>
<td align="center">22</td>
<td align="center">
<italic>17,719</italic>
</td>
</tr>
<tr>
<td align="left">SARS virus</td>
<td align="center">1</td>
<td align="center">
<italic>1743</italic>
</td>
<td align="center">
<italic>926</italic>
</td>
<td align="center">301</td>
<td align="center">115</td>
<td align="center">576</td>
</tr>
<tr>
<td align="left">Severe acute respiratory syndrome</td>
<td align="center">1</td>
<td align="center">
<italic>1,465</italic>
</td>
<td align="center">569</td>
<td align="center">230</td>
<td align="center">77</td>
<td align="center">393</td>
</tr>
<tr>
<td align="left">Respiratory tract diseases</td>
<td align="left"/>
<td align="center">
<italic>1,617</italic>
</td>
<td align="center">
<italic>911</italic>
</td>
<td align="center">
<italic>696</italic>
</td>
<td align="center">346</td>
<td align="center">
<italic>17,785</italic>
</td>
</tr>
<tr>
<td align="left">Amino acids, peptides, and proteins</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>1756</italic>
</td>
<td align="left"/>
<td align="center">
<italic>930</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Biological phenomena</td>
<td align="left"/>
<td align="left"/>
<td align="center">542</td>
<td align="center">
<italic>677</italic>
</td>
<td align="center">
<italic>521</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Middle East respiratory syndrome coronavirus</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>625</italic>
</td>
<td align="center">
<italic>500</italic>
</td>
<td align="center">165</td>
</tr>
<tr>
<td align="left">Health care quality, access, and evaluation</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>587</italic>
</td>
<td align="center">7,365</td>
</tr>
<tr>
<td align="left">Eukaryota</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,968</italic>
</td>
</tr>
<tr>
<td align="left">Animals</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,967</italic>
</td>
</tr>
<tr>
<td align="left">Vertebrates</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,947</italic>
</td>
</tr>
<tr>
<td align="left">Chordata</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,947</italic>
</td>
</tr>
<tr>
<td align="left">Mammals</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,939</italic>
</td>
</tr>
<tr>
<td align="left">Eutheria</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,938</italic>
</td>
</tr>
<tr>
<td align="left">Primates</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,845</italic>
</td>
</tr>
<tr>
<td align="left">Haplorhini</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,843</italic>
</td>
</tr>
<tr>
<td align="left">Catarrhini</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,842</italic>
</td>
</tr>
<tr>
<td align="left">Hominidae</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,813</italic>
</td>
</tr>
<tr>
<td align="left">Humans</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,812</italic>
</td>
</tr>
<tr>
<td align="left">Environment and public health</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,778</italic>
</td>
</tr>
<tr>
<td align="left">Public health</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,773</italic>
</td>
</tr>
<tr>
<td align="left">Lung diseases</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>17,741</italic>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Italic numbers represent the number of appearances of keywords ranked in top 25. We sorted the order based on the total number in &#x201c;1996&#x2013;2002.&#x201d;</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>By Author: Identifying Converted Experts</title>
<p>The increase in the number of coronavirus-related articles after the outbreaks of SARS, MERS, and COVID-19 was largely due to the entry of new researchers (<xref ref-type="sec" rid="s9">Supplementary Table S2</xref>). For example, between 2015 and 2019, a total of 24,745 authors with specific affiliations were identified in coronavirus-related articles. Their names with the same affiliations were found in only 369 out of 39,804 (0.9%) coronavirus-related articles in 2020. In the case of SARS, the authors of publications between 1998 and 2002 accounted for 23 out of 2,805 (0.8%) published articles on coronavirus between 2003 and 2006. In the case of MERS, the authors from the years between 2008 and 2012 occupied 123 out of 3,052 (4.0%) coronavirus-related articles published between 2013 and 2016. As a reference, we also analyzed the case of &#x201c;Influenza,&#x201d; resulting in a higher rate of occupation [the authors from the years between 2014 and 2018 occupied 1,364 out of 5,542&#x20;influenza-related articles published in 2019 (24.6%)]. Here, because not all affiliations were attached to the authors in PubMed before 2014 (<xref ref-type="sec" rid="s9">Supplementary Table S3</xref>), the authors regardless of their affiliations were counted in (<xref ref-type="sec" rid="s9">Supplementary Table S4</xref>). The risk of counting different authors as the same authors had to be taken. In any case, the results of this investigation show that most of these converted experts were conducting their coronavirus research on a temporary basis as they did not continue publishing on coronaviruses after new outbreaks.</p>
<p>This study then examined unique keywords used by the newcomers to coronavirus research from the past 5&#xa0;years (searched by their names with affiliations). Those listed as top 25 frequently appeared unique keywords used by the newly entered researchers (<xref ref-type="table" rid="T2">Table&#x20;2</xref>) did not largely overlap with those of coronavirus research between 1996 and 2020 (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) (11 out of 72 keywords). This tendency did not change when we compared them with top 50 frequently appeared unique keywords (<xref ref-type="sec" rid="s9">Supplementary TablesS1, S5</xref>). Thus, it is likely that such new researchers came from different disciplines.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Top 25 unique keywords used by newly entered researchers in the&#x20;past.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">MeSH</th>
<th align="center">1998&#x2013;2002 Author in 2003&#x2013;2006</th>
<th align="center">2008&#x2013;2012 Author in 2013&#x2013;2016</th>
<th align="center">2015&#x2013;2020 Author in 2020</th>
<th align="center">MeSH</th>
<th align="center">1998&#x2013;2002 Author in 2003&#x2013;2006</th>
<th align="center">2008&#x2013;2012 Author in 2013&#x2013;2016</th>
<th align="center">2015&#x2013;2020 Author in 2020</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Number of articles</td>
<td align="center">70</td>
<td align="center">681</td>
<td align="center">49,798</td>
<td align="left">Number of articles</td>
<td align="center">70</td>
<td align="center">681</td>
<td align="center">49,798</td>
</tr>
<tr>
<td align="left">Infections</td>
<td align="center">
<italic>28</italic>
</td>
<td align="center">
<italic>176</italic>
</td>
<td align="left"/>
<td align="left">History</td>
<td align="center">5</td>
<td align="center">
<italic>69</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Genetic phenomena</td>
<td align="center">
<italic>25</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Animal diseases</td>
<td align="center">5</td>
<td align="center">
<italic>46</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Information science</td>
<td align="center">
<italic>20</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">History, Modern 1601-</td>
<td align="center">4</td>
<td align="center">
<italic>58</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Bacterial infections and mycoses</td>
<td align="center">
<italic>16</italic>
</td>
<td align="center">
<italic>44</italic>
</td>
<td align="left"/>
<td align="left">Respiratory tract infections</td>
<td align="center">3</td>
<td align="center">
<italic>50</italic>
</td>
<td align="center">
<italic>963</italic>
</td>
</tr>
<tr>
<td align="left">Nucleic acids, nucleotides, and nucleosides</td>
<td align="center">
<italic>16</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Orthomyxoviridae</td>
<td align="center">3</td>
<td align="center">
<italic>47</italic>
</td>
<td align="center">373</td>
</tr>
<tr>
<td align="left">Genetic structures</td>
<td align="center">
<italic>16</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Influenza A virus</td>
<td align="center">3</td>
<td align="center">
<italic>47</italic>
</td>
<td align="center">321</td>
</tr>
<tr>
<td align="left">Genetic techniques</td>
<td align="center">
<italic>16</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Influenza A virus</td>
<td align="center">3</td>
<td align="center">
<italic>47</italic>
</td>
<td align="center">319</td>
</tr>
<tr>
<td align="left">Nucleic acids</td>
<td align="center">
<italic>16</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Organizations</td>
<td align="center">3</td>
<td align="center">41</td>
<td align="center">
<italic>1,145</italic>
</td>
</tr>
<tr>
<td align="left">Bacteria</td>
<td align="center">
<italic>15</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Antiviral agents</td>
<td align="center">3</td>
<td align="center">15</td>
<td align="center">
<italic>624</italic>
</td>
</tr>
<tr>
<td align="left">Genome</td>
<td align="center">
<italic>15</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Orthomyxoviridae infections</td>
<td align="center">2</td>
<td align="center">
<italic>50</italic>
</td>
<td align="center">427</td>
</tr>
<tr>
<td align="left">Biological science disciplines</td>
<td align="center">
<italic>15</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Influenza, human</td>
<td align="center">2</td>
<td align="center">
<italic>42</italic>
</td>
<td align="center">355</td>
</tr>
<tr>
<td align="left">Natural science disciplines</td>
<td align="center">
<italic>15</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">United&#x20;Kingdom</td>
<td align="center">2</td>
<td align="left"/>
<td align="center">
<italic>1,265</italic>
</td>
</tr>
<tr>
<td align="left">Viruses</td>
<td align="center">
<italic>14</italic>
</td>
<td align="center">
<italic>100</italic>
</td>
<td align="center">
<italic>2079</italic>
</td>
<td align="left">Social sciences</td>
<td align="left"/>
<td align="center">
<italic>162</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Bacterial infections</td>
<td align="center">
<italic>14</italic>
</td>
<td align="center">
<italic>42</italic>
</td>
<td align="left"/>
<td align="left">Health care economics and organizations</td>
<td align="left"/>
<td align="center">
<italic>96</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Molecular structure</td>
<td align="center">
<italic>13</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Social control, formal</td>
<td align="left"/>
<td align="center">
<italic>70</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Information services</td>
<td align="center">
<italic>12</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Respiratory tract diseases</td>
<td align="left"/>
<td align="center">
<italic>64</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Virus diseases</td>
<td align="center">
<italic>11</italic>
</td>
<td align="center">
<italic>126</italic>
</td>
<td align="center">
<italic>2,903</italic>
</td>
<td align="left">Medicine</td>
<td align="left"/>
<td align="center">
<italic>56</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Immunologic techniques</td>
<td align="center">
<italic>11</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Philosophy</td>
<td align="left"/>
<td align="center">
<italic>43</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Genome components</td>
<td align="center">
<italic>11</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Communications media</td>
<td align="left"/>
<td align="center">
<italic>43</italic>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Biology</td>
<td align="center">
<italic>11</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Physicians</td>
<td align="left"/>
<td align="center">18</td>
<td align="center">
<italic>756</italic>
</td>
</tr>
<tr>
<td align="left">Blood proteins</td>
<td align="center">
<italic>11</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Flaviviridae infections</td>
<td align="left"/>
<td align="center">7</td>
<td align="center">
<italic>625</italic>
</td>
</tr>
<tr>
<td align="left">Genes</td>
<td align="center">
<italic>10</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Survival analysis</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>1,658</italic>
</td>
</tr>
<tr>
<td align="left">Sociology</td>
<td align="center">
<italic>9</italic>
</td>
<td align="center">
<italic>113</italic>
</td>
<td align="left"/>
<td align="left">Mortality</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>1,522</italic>
</td>
</tr>
<tr>
<td align="left">Social problems</td>
<td align="center">
<italic>9</italic>
</td>
<td align="center">41</td>
<td align="left"/>
<td align="left">Health planning</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>1,436</italic>
</td>
</tr>
<tr>
<td align="left">Warfare and armed conflicts</td>
<td align="center">
<italic>9</italic>
</td>
<td align="center">3</td>
<td align="left"/>
<td align="left">National health programs</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>912</italic>
</td>
</tr>
<tr>
<td align="left">Warfare</td>
<td align="center">
<italic>9</italic>
</td>
<td align="center">3</td>
<td align="left"/>
<td align="left">State medicine</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>835</italic>
</td>
</tr>
<tr>
<td align="left">Molecular sequence data</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Survival rate</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>774</italic>
</td>
</tr>
<tr>
<td align="left">Computational biology</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Urologic surgical procedures</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>744</italic>
</td>
</tr>
<tr>
<td align="left">Hemic and immune systems</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Guidelines as topic</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>678</italic>
</td>
</tr>
<tr>
<td align="left">Proteobacteria</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Controlled clinical trials as topic</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>659</italic>
</td>
</tr>
<tr>
<td align="left">Gram-negative bacteria</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Randomized controlled trials as topic</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>651</italic>
</td>
</tr>
<tr>
<td align="left">Documentation</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Registries</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>647</italic>
</td>
</tr>
<tr>
<td align="left">Base sequence</td>
<td align="center">
<italic>9</italic>
</td>
<td align="left"/>
<td align="left"/>
<td align="left">Radiotherapy</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>641</italic>
</td>
</tr>
<tr>
<td align="left">RNA viruses</td>
<td align="center">8</td>
<td align="center">
<italic>88</italic>
</td>
<td align="center">
<italic>1,571</italic>
</td>
<td align="left">Prostatic diseases</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>594</italic>
</td>
</tr>
<tr>
<td align="left">RNA virus infections</td>
<td align="center">7</td>
<td align="center">
<italic>110</italic>
</td>
<td align="center">
<italic>2,261</italic>
</td>
<td align="left">Practice guidelines as topic</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>589</italic>
</td>
</tr>
<tr>
<td align="left">Humanities</td>
<td align="center">6</td>
<td align="center">
<italic>141</italic>
</td>
<td align="left"/>
<td align="left">Proportional hazard models</td>
<td align="left"/>
<td align="left"/>
<td align="center">
<italic>580</italic>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Italic numbers represent the number of appearances of keywords ranked in top 25. We sorted the order based on the total number in &#x201c;1998&#x2013;2002 author in 2003&#x2013;2006.&#x201d;</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>After the outbreak of SARS, experts on &#x201c;infection of RNA viruses and bacteria especially in the fields of immunology, molecular biology, bioinformatics, and/or sociology&#x201d; began to take part in coronavirus studies (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). In the case of MERS, many RNA virus researchers handling &#x201c;influenza virus infection&#x201d; and &#x201c;HIV infection&#x201d; as well as experts on &#x201c;health-care issues&#x201d; joined in (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>). In the case of COVID-19, it attracted experts on the &#x201c;hepatitis virus&#x201d; and &#x201c;<italic>mycobacterium</italic>&#x201d; (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Networks of Top 50 unique keywords used by newcomers to coronavirus research. <bold>(A)</bold> The networks of top 50 unique keywords in 1998&#x2013;2002, which were used by those researchers who converted to coronavirus research in 2003&#x2013;2006. <bold>(B)</bold> The networks of top 50 unique keywords in 2008&#x2013;2012, which were used by those who started coronavirus research in 2013&#x2013;2016. <bold>(C)</bold> The networks of top 50 unique keywords in 2015&#x2013;2019, which were used by those who converted to coronavirus research in 2020. The node colors represent the fields related to the keywords (green: virus and its infection; light green: molecular biology, microbiology, and immunology; orange: health care and policy; light orange: humanity and social issues; blue: epidemiology; gray: other issues). The threshold for making edges was set at 10% of the number of keywords (selecting smaller sized nodes) linked by the&#x20;edges.</p>
</caption>
<graphic xlink:href="fdata-04-631073-g002.tif"/>
</fig>
<p>Furthermore, for COVID-19, many converted experts had no background in the research on &#x201c;RNA virus and infection.&#x201d; They consequently formed a separate scientific network apart from those with their background in &#x201c;RNA viruses and infections&#x201d; in the beginning. They started from forming networks with those with their background in &#x201c;urology and prostate,&#x201d;&#x201c;diagnosis of digestive system,&#x201d;&#x201c;clinical trial,&#x201d; or &#x201c;health care and guide line planning,&#x201d;&#x201c;jurisprudence,&#x201d;&#x201c;public policy,&#x201d; and others. Such outside-in networking, due to the wide disciplinary base of the network, was one of the characteristics of COVID-19 research dynamics in the beginning.</p>
</sec>
<sec id="s3-3">
<title>By Nationality: The Prioritization of National Contingencies as an International Trend</title>
<p>Once a novel infectious disease emerges in a certain country, scientific publications on the disease increase in the corresponding country (<xref ref-type="table" rid="T3">Table&#x20;3</xref> and <xref ref-type="sec" rid="s9">Supplementary Table S6</xref>). The United&#x20;States and Germany have always been ranked among top 10 countries frequently publishing coronavirus articles, regardless of contingencies involving novel coronaviruses&#x2014;suggesting that these countries have been the leaders of coronavirus research over the past 25&#xa0;years. China became the No. 2 country after the SARS outbreak in November 2002 in China. Taiwan, Hong Kong, Singapore, and Canada&#x2014;the countries and regions that prevailed after being hit hard by SARS in 2003 (<xref ref-type="bibr" rid="B4">Chan-Yeung and Xu, 2003</xref>; <xref ref-type="bibr" rid="B19">Wallinga and Teunis, 2004</xref>)&#x2014;were also in top 10 between 2003 and 2006. In the case of the MERS outbreak in November 2012, Saudi Arabia was ranked among top 10 as one of the major countries that overcame the epidemic. Korea was also ranked among top 10 countries between 2013 and 2016, quite possibly due to the outbreak of the MERS epidemic in Korea in 2015 (<xref ref-type="bibr" rid="B6">Chen et&#x20;al., 2017</xref>). With regard to the case of COVID-19, the exponential increase in the number of scientific publications originating from all the countries examined in this article suggests its impact on a global scale. It was also found that many researchers converted to the field of coronavirus studies after the outbreaks of infectious diseases (<xref ref-type="sec" rid="s9">Supplementary Table S7</xref>). Accordingly, the outbreaks of novel coronavirus diseases accelerate coronavirus research activities in the affected countries by attracting new researchers.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Top 10 countries for coronavirus articles in each period.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">1996&#x2013;2002</th>
<th align="center">2003&#x2013;2006</th>
<th align="center">2007&#x2013;2012</th>
<th align="center">2013&#x2013;2016</th>
<th align="center">2017&#x2013;2019</th>
<th align="center">2020 Jan&#x2013;Aug</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">United&#x20;States</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">2</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Japan</td>
<td align="center">2</td>
<td align="center">8</td>
<td align="center">4</td>
<td align="center">7</td>
<td align="center">6</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Canada</td>
<td align="center">3</td>
<td align="center">6</td>
<td align="center">6</td>
<td align="left"/>
<td align="center">5</td>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Germany</td>
<td align="center">4</td>
<td align="center">5</td>
<td align="center">7</td>
<td align="center">3</td>
<td align="center">4</td>
<td align="center">7</td>
</tr>
<tr>
<td align="left">Spain</td>
<td align="center">5</td>
<td align="left"/>
<td align="center">9</td>
<td align="left"/>
<td align="left"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">France</td>
<td align="center">6</td>
<td align="center">10</td>
<td align="left"/>
<td align="center">4</td>
<td align="center">7</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">Italy</td>
<td align="center">7</td>
<td align="center">9</td>
<td align="center">8</td>
<td align="left"/>
<td align="center">9</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">Switzerland</td>
<td align="center">8</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Singapore</td>
<td align="center">9</td>
<td align="center">7</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Australia</td>
<td align="center">10</td>
<td align="left"/>
<td align="center">10</td>
<td align="center">9</td>
<td align="left"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Belgium</td>
<td align="center">10</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">United&#x20;Kingdom</td>
<td align="center">10</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Korea</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">8</td>
<td align="center">8</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Taiwan</td>
<td align="left"/>
<td align="center">4</td>
<td align="center">5</td>
<td align="center">10</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">China</td>
<td align="left"/>
<td align="center">2</td>
<td align="center">2</td>
<td align="center">2</td>
<td align="center">1</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">Hong Kong</td>
<td align="left"/>
<td align="center">3</td>
<td align="center">3</td>
<td align="center">6</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">India</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">4</td>
</tr>
<tr>
<td align="left">Saudi Arabia</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">5</td>
<td align="center">3</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Egypt</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">10</td>
<td align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The value in each column represents the ranking for the number of articles published from the corresponding country in each period. We sorted the order based on the total number in &#x201c;1996&#x2013;2002.&#x201d;</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The proportion of internationally co-authored articles on coronaviruses to all the coronavirus-related articles among the countries listed in <xref ref-type="sec" rid="s9">Supplementary Table S6</xref> was 0.22&#x2013;0.26 between 2016 and 2019 (<xref ref-type="sec" rid="s9">Supplementary Table S8</xref>). This rate was higher than that of all the internationally co-authored articles during the same period (0.16&#x2013;0.18). Thus, compared with the average collaboration ratio of articles, a higher rate of transnational collaboration was present for coronavirus research. In contrast, in 2020 after the outbreak of COVID-19, the rate of internationally co-authored coronavirus articles was 0.16. This was lower than the rate of all the international research articles published in the same year (0.19). In this way, transnational collaboration on coronavirus research as indicated in the rate of international co-authorships has decreased since the outbreak of COVID-19.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>This study investigated the dynamics of research on COVID-19 (SARS-CoV-2) by comparing it to the previous cases of SARS (SARS-CoV) and MERS (MERS-CoV). Results show two different modes of research dynamics with regard to the scale of social impact as follows:1) in the cases of two regional pandemics, SARS and MERS, the scope of cross-disciplinary research remained between neighboring research areas as experts on surrounding research areas joined the networks of coronavirus experts; 2) in the case of the global pandemic, COVID-19, with overwhelming global impact, cross-disciplinary activities have spread far beyond neighboring areas of research to form new research networks. These dynamics of cross-disciplinary research are national in character as newly converted researchers came from the countries seriously affected by the coronaviruses. However, the majority of these converted experts are likely to conduct their coronavirus research on a temporary basis, and they might change their research subjects once an outbreak is over. Such temporary participation of researchers in coronavirus research suggests that securing the source of funding could be one of the factors for sustaining transdisciplinary research on coronaviruses and lowering the fatality of future outbreaks.</p>
<p>Knowledge on COVID-19 is distributed across a wide range of disciplines forming research networks within national boundaries. More technically, while MeSH terms may not be sufficient to completely identify the background of authors with different roles, this research shows that MeSH terms are still useful to the extent that they help identify the scope of cross-disciplinarity regarding coronavirus research. It would also be valuable to examine the dynamics of research beyond those fields covered by PubMed to further unveil the impact of COVID-19 on an even wider range of research activities in the&#x20;world.</p>
<p>In short, COVID-19 has transformed the structure of coronavirus research. The greater the scale of social impact is, the more cross-disciplinary research emerges. In the case of COVID-19, the national character of research has been reinforced by the finding that transnational collaboration in terms of international co-authorships has decreased since the outbreak of the global pandemic. Given the unprecedented scale of COVID-19 and the nationalization of responses, the most likely way forward for medical experts is to accumulate local knowledge with the awareness of transdisciplinary research dynamics. For a coordinated response to COVID-19, an implication here is to be aware of the perspective that the global pandemic can be grasped into a bodily event for each medical and nonmedical expert to become an extension to a transdisciplinary solution to the health problem of the one and the many. An &#x201c;event&#x201d; or a &#x201c;prehension&#x201d; (apprehension which may or may not be cognitive) of things, here in this place such as a local response to the COVID-19 pandemic, has reference to other places since things gathered into the grasped unity of an event as a spatiotemporal unity here and now have essential reference to other places and other times (<xref ref-type="bibr" rid="B21">Whitehead, 1925</xref>). Events are prehensions of things that constitute realities of nature given that nature is a structure of evolving &#x201c;processes&#x201d; and each single event within its own context has all the reality that is interlocked with the whole (<xref ref-type="bibr" rid="B21">Whitehead, 1925</xref>). Finally, while the present study&#x2014;with its focus on the articles published by August 17, 2020&#x2014;demonstrated the initial impact of COVID-19, continuous research is still necessary to grasp the further transformation of research dynamics in the long-term challenge against COVID-19.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>; further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>All the authors contributed to this work and approved the final version for submission. RO and JK wrote the article. RO carried out the data collection and the analyses reported in this study. MF helped informing the discussion. OO supervised the&#x20;study.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work has been funded by the Japan Society for the Promotion of Science as Grant-in-Aid for Scientific Research (C) to RO (20K00266), and by the University of Tsukuba as a research support program to tackle COVID-19&#x2013;related emergency problems to&#x20;RO, JK, MF, and OO.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fdata.2021.631073/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fdata.2021.631073/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batagelj</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mrvar</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Pajek- Analysis and Visualization of Large Networks</article-title>. <source>Graph Drawing</source>
<volume>2265</volume>, <fpage>477</fpage>&#x2013;<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1007/3-540-45848-4_54</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borup</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Van Lente</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The Sociology of Expectations in Science and Technology</article-title>. <source>Technol. Anal.Strateg.Manage.</source>
<volume>18</volume>, <fpage>285</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1080/09537320600777002</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cauchemez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Van Kerkhove</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rambaut</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Middle East Respiratory Syndrome Coronavirus: Quantification of the Extent of the Epidemic, Surveillance Biases, and Transmissibility</article-title>. <source>Lancet Infect. Dis.</source>
<volume>14</volume>, <fpage>50</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/s1473-3099(13)70304-9</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan-Yeung</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.-H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>SARS: Epidemiology</article-title>. <source>Respirology</source>
<volume>8</volume> (<issue>Suppl. l</issue>), <fpage>S9</fpage>&#x2013;<lpage>S14</lpage>. <pub-id pub-id-type="doi">10.1046/j.1440-1843.2003.00518.x</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Channappanavar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Perlman</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Pathogenic Human Coronavirus Infections: Causes and Consequences of Cytokine Storm and Immunopathology</article-title>. <source>Semin.Immunopathol</source>
<volume>39</volume>, <fpage>529</fpage>&#x2013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-017-0629-x</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chughtai</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Dyda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Macintyre</surname>
<given-names>C.R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Comparative Epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Saudi Arabia and South Korea</article-title>. <source>Emerg. Microbes Infect.</source>
<volume>6</volume>, <fpage>e51</fpage>. <pub-id pub-id-type="doi">10.1038/emi.2017.40</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarner</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Three Emerging Coronaviruses in Two Decades</article-title>. <source>Am. J.Clin.Pathol.</source>
<volume>153</volume>, <fpage>420</fpage>&#x2013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1093/ajcp/aqaa029</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gustafsson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kuusi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Examining Open-Endedness of Expectations in Emerging Technological fields: The Case of Cellulosic Ethanol</article-title>. <source>Technol. Forecast.Soc. Change</source>
<volume>91</volume>, <fpage>179</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.techfore.2014.02.008</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hijawi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Abdallat</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sayaydeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alqasrawi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Haddadin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jaarour</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Novel Coronavirus Infections in Jordan, April 2012: Epidemiological Findings from a Retrospective Investigation</article-title>. <source>East.Mediterr. Health J.</source>
<volume>19</volume> (<issue>Suppl. 1</issue>), <fpage>S12</fpage>&#x2013;<lpage>S18</lpage>. <pub-id pub-id-type="doi">10.26719/2013.19.supp1.s12</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Lipscomb</surname>
<given-names>C. E.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Medical Subject Headings (MeSH)</article-title>. <source>Bull Med. Libr. Assoc.</source> <volume>88</volume>, <fpage>265</fpage>&#x2013;<lpage>266</lpage>.</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowe</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>G.O.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Understanding and Using the Medical Subject Headings (MeSH) Vocabulary to Perform Literature Searches</article-title>. <source>Jama-Journal Am. Med. Assoc.</source>
<volume>271</volume>, <fpage>1103</fpage>&#x2013;<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1001/jama.271.14.1103</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohniwa</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Hibino</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Generating Process of Emerging Topics in the Life Sciences</article-title>. <source>Scientometrics</source>
<volume>121</volume>, <fpage>1549</fpage>&#x2013;<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-019-03248-z</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohniwa</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Hibino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takeyasu</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Trends in Research Foci in Life Science fields over the Last 30&#x20;Years Monitored by Emerging Topics</article-title>. <source>Scientometrics</source>
<volume>85</volume>, <fpage>111</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-010-0252-2</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosling</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rosling</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Pneumonia Causes Panic in Guangdong Province</article-title>. <source>BMJ</source>
<volume>326</volume>, <fpage>416</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.326.7386.416</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotolo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B. R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>What Is an Emerging Technology?</article-title>. <source>Res.Pol.</source>
<volume>44</volume>, <fpage>1827</fpage>&#x2013;<lpage>1843</lpage>. <pub-id pub-id-type="doi">10.1016/j.respol.2015.06.006</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singhal</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A Review of Coronavirus Disease-2019 (COVID-19)</article-title>. <source>Indian J.Pediatr.</source> <volume>87</volume>, <fpage>281</fpage>&#x2013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1007/s12098-020-03263-6</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Stenner</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). &#x201c;<source>Liminality and Experience A Transdisciplinary Approach to the Psychosocial,</source> (<publisher-loc>London</publisher-loc>: <publisher-name>Palgrave Macmillan UK Imprint</publisher-name>). <pub-id pub-id-type="doi">10.1057/978-1-137-27211-9</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Merkerk</surname>
<given-names>R. O.</given-names>
</name>
<name>
<surname>Van Lente</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Tracing Emerging Irreversibilities in Emerging Technologies: The Case of Nanotubes</article-title>. <source>Technol. Forecast.Soc. Change</source>
<volume>72</volume>, <fpage>1094</fpage>&#x2013;<lpage>1111</lpage>. <pub-id pub-id-type="doi">10.1016/j.techfore.2004.10.003</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallinga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Teunis</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures</article-title>. <source>Am. J.Epidemiol.</source>
<volume>160</volume>, <fpage>509</fpage>&#x2013;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwh255</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Unique Epidemiological and Clinical Features of the Emerging 2019 Novel Coronavirus Pneumonia (COVID&#x2010;19) Implicate Special Control Measures</article-title>. <source>J.&#x20;Med.Virol.</source>
<volume>92</volume>, <fpage>568</fpage>&#x2013;<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25748</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Whitehead</surname>
<given-names>A. N.</given-names>
</name>
</person-group> (<year>1925</year>). <source>Science and the Modern World Lowell Lectures, 1925</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>The Macmillan company</publisher-name>.</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>R.-H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>G.-W.</given-names>
</name>
<name>
<surname>Field</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D.-W.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Epidemiologic Clues to SARS Origin in China</article-title>. <source>Emerg. Infect. Dis.</source>
<volume>10</volume>, <fpage>1030</fpage>&#x2013;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.3201/eid1006.030852</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>